Great News for Psychedelics Companies – Journey Clinical Raised $3M Funding For Mental Health Treatment Sep 30, 2021
atai Launches Revixia Life Sciences to Develop Salvinorin A for a Variety of Mental Health Conditions Aug 12, 2021
COMPASS Pathways plc announces financial results and business highlights for the second quarter 2021 Aug 11, 2021
PsyBio Therapeutics Adds NMDA Receptor Antagonists and Associated Analogues into its Intellectual Property Portfolio Aug 4, 2021
